Trial intelligence / Profile preview

Pioglitazone and Serum ADMA in Patients With Diabetes

NCT00770367Phase 4Completed

Sponsor
Medical University of South Carolina
Start
Oct 2008
Primary completion
Dec 2009
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of pioglitazone in type 2 diabetes mellitus (T2DM), sponsored by Medical University of South Carolina. Started Oct 2008; status: completed.

02

Drugs

pioglitazone
03

Conditions

type 2 diabetes mellitus (T2DM)

Beyond the preview

Go deeper on NCT00770367.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00770367.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call